Archives
-
0.4% Trypan Blue Solution: Practical Guide
2026-09-30
The 0.4% Trypan Blue Solution supports rapid cell viability measurement, cell counting, and live/dead cell discrimination by staining cells with compromised membranes. It is intended for controlled research workflows, including cytotoxicity assays, and is not suitable for diagnostic, clinical, or medical use.
-
AO/PI Double Staining Kit for Cell Viability
2026-09-30
The AO/PI Double Staining Kit delivers rapid three-state discrimination of viable, apoptotic, and necrotic cells in one fluorescent workflow. This guide shows how to adapt the assay for cytotoxicity screens, post-enrichment cell assessment, and rare-cell studies while preserving practical controls and troubleshooting discipline.
-
Live-Dead Cell Staining Kit I in Hypoxia Studies
2026-09-29
Discover how the Live-Dead Cell Staining Kit I (Calcein AM/PI) can serve as a decision layer for evaluating hypoxia-activated cancer therapeutics. This article connects membrane integrity and intracellular esterase activity with the mechanistic questions raised by photomolecular glue research.
-
E. coli Uracil-DNA Glycosylase (UDG) Guide
2026-09-29
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from compatible single- and double-stranded DNA to support PCR product contamination elimination and DNA damage repair research. It is not intended for RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.
-
From Esculin Biology to Actionable Cell Death Data
2026-09-28
Esculin research in renal cell carcinoma illustrates why translational teams need more than viability endpoints. This article explains how dual Hoechst 33342 and propidium iodide fluorescence can connect chromatin changes, membrane integrity, and mechanistic evidence in a practical cell-death workflow.
-
Optimized GBA1 mRNA for Gaucher Disease
2026-09-28
A 2026 study optimized human GBA1 mRNA through changes to untranslated regions, codon usage, and poly(A) tails, improving glucocerebrosidase expression and persistence in cell models. The optimized mRNA also restored lysosomal phenotypes in GBA1-knockout cells, while lipid nanoparticle delivery produced detectable enzyme activity in mouse liver and spleen.
-
P2Y11 Signaling as a Translational Control Point
2026-09-27
A translational framework for using NF 340 to investigate the proposed QPRT–P2Y11–myosin connection, with practical guidance on evidence, assay design, and the limits of extrapolation.
-
Puromycin Dihydrochloride for GBM Research
2026-09-26
Use Puromycin dihydrochloride to establish pac-positive cell models and add a carefully controlled translation readout to glioblastoma signaling studies. A practical workflow connects this aminonucleoside antibiotic to research on the BCKDK–STUB1–BCAT1 axis—without confusing puromycin’s global effects on translation with pathway-specific changes.
-
BODIPY 581/591 C11 for Lipid Peroxidation Assays
2026-09-25
Use BODIPY 581/591 C11 to track membrane lipid oxidation through a red-to-green fluorescence shift, rather than treating it as a general-purpose ROS meter. This practical workflow shows how to apply the ratiometric readout to cardiovascular oxidative-injury studies, including follow-up experiments on antioxidant nanozymes, while controlling for probe handling and optical interference.
-
From HOXC9 Signaling to Apoptosis Assay Strategy
2026-09-25
HOXC9-linked AKT/mTOR activity offers a mechanistic lens on esophageal squamous cell carcinoma. Here, we connect that evidence to practical apoptosis assay design and translational decision-making with the Annexin V-HF647/PI Apoptosis Kit.
-
Tin Mesoporphyrin IX: HO Assay Workflows
2026-09-24
Use Tin Mesoporphyrin IX (chloride) to test whether a biological response depends on heme oxygenase catalytic activity—not simply on HO-1 expression. This guide connects nanomolar enzyme-assay design with cautious cell-based follow-up, including controls for redox studies and common porphyrin-related readout artifacts.
-
0.4% Trypan Blue Solution: Practical Cell Counting
2026-09-24
0.4% Trypan Blue Solution supports endpoint cell viability measurement by staining cells with compromised membranes, helping researchers distinguish them from unstained cells during routine counts. It is intended for research workflows such as cell culture and cytotoxicity assays, not for diagnostic or medical use, and it does not identify the mechanism of cell death.
-
IDO1 Inhibition Can Activate Tumor-Protective STAT3
2026-09-23
In a syngeneic CT26 tumor model, pharmacological apo-IDO1 inhibition activated antitumor immune populations but also promoted myeloid IL-6 signals linked to tumor-cell JAK2/STAT3 activation. The study highlights a potential compensatory survival response and provides a rationale—not proof of clinical benefit—for testing IDO1 blockade alongside pathway-directed inhibition.
-
PtrbZIP12 Links Phosphorylation to Poplar Drought Tolerance
2026-09-23
The reference study identifies PtrbZIP12 as a regulatory hub that improves Populus trichocarpa drought resistance by directly activating PtrDHN and PtrPOD. Its combination of transgenic genetics, transcriptomics, DNA-binding assays, and phosphorylation analysis connects transcriptional regulation with reactive oxygen species control and stress adaptation.
-
ONX-0914 (PR-957): Selective LMP7 Inhibition
2026-09-22
ONX-0914, also called PR-957, is a selective immunoproteasome inhibitor that targets LMP7 and modulates inflammatory cytokine production. Its strongest evidence supports mechanistic studies of immunoproteasome inhibition in autoimmune disease, while mouse and CNS findings do not establish human therapeutic efficacy.